Henry Schein (NASDAQ:HSIC) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Henry Schein (NASDAQ:HSIC) from a buy rating to a strong-buy rating in a report published on Saturday.

Several other research firms have also weighed in on HSIC. JPMorgan Chase & Co. upped their price target on Henry Schein from $78.00 to $92.00 and gave the company an “overweight” rating in a research report on Wednesday, February 25th. Mizuho raised their price objective on Henry Schein from $81.00 to $88.00 and gave the stock a “neutral” rating in a research report on Wednesday, February 25th. Wells Fargo & Company lifted their target price on Henry Schein from $76.00 to $87.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 25th. Leerink Partners reiterated a “market perform” rating on shares of Henry Schein in a report on Monday, March 9th. Finally, BTIG Research assumed coverage on shares of Henry Schein in a research report on Thursday. They issued a “neutral” rating for the company. Seven investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Henry Schein presently has a consensus rating of “Hold” and an average price target of $86.69.

Henry Schein Trading Up 0.4%

Henry Schein stock opened at $79.15 on Friday. Henry Schein has a 52 week low of $61.94 and a 52 week high of $89.29. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.76 and a current ratio of 1.38. The firm has a market capitalization of $9.08 billion, a price-to-earnings ratio of 24.20, a P/E/G ratio of 2.33 and a beta of 0.88. The company has a 50 day moving average price of $76.89 and a 200 day moving average price of $74.16.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, February 24th. The company reported $1.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.30 by $0.04. The company had revenue of $3.44 billion for the quarter, compared to the consensus estimate of $3.34 billion. Henry Schein had a net margin of 3.02% and a return on equity of 15.16%. The company’s revenue was up 7.7% on a year-over-year basis. During the same period in the previous year, the business earned $1.19 EPS. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. Research analysts forecast that Henry Schein will post 5.3 EPS for the current year.

Insider Transactions at Henry Schein

In other Henry Schein news, Director Philip A. Laskawy sold 2,844 shares of the company’s stock in a transaction dated Thursday, March 5th. The stock was sold at an average price of $80.36, for a total value of $228,543.84. Following the transaction, the director directly owned 21,961 shares of the company’s stock, valued at $1,764,785.96. This represents a 11.47% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Kurt P. Kuehn sold 2,844 shares of the firm’s stock in a transaction dated Tuesday, March 10th. The stock was sold at an average price of $78.96, for a total value of $224,562.24. Following the sale, the director directly owned 15,420 shares of the company’s stock, valued at $1,217,563.20. This trade represents a 15.57% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 105,911 shares of company stock valued at $8,574,982. Corporate insiders own 1.14% of the company’s stock.

Institutional Trading of Henry Schein

Institutional investors have recently added to or reduced their stakes in the business. CYBER HORNET ETFs LLC acquired a new position in shares of Henry Schein during the 2nd quarter worth $25,000. MUFG Securities EMEA plc acquired a new stake in shares of Henry Schein in the 2nd quarter valued at $27,000. Flagship Harbor Advisors LLC acquired a new stake in shares of Henry Schein in the 4th quarter valued at $30,000. Federated Hermes Inc. bought a new stake in Henry Schein in the fourth quarter worth $32,000. Finally, Los Angeles Capital Management LLC bought a new stake in Henry Schein in the fourth quarter worth $37,000. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Company Profile

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.